Literature DB >> 31734282

Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension.

Katerina Simkova1, Berndt Joost2, Georgios Imanidis3.   

Abstract

We combined high-energy wet media milling and spray drying to engineer dry powders for inhalation consisting of geometrically large, low-density particles with superior aerodynamic properties and fast dissolution. Peclet number proved to be a useful instrument to guide choice of the additives and process conditions for generating low-density powders by spray drying. Composite dry powders consisted of milled and stabilized budesonide nanoparticles, leucine or albumin as matrix formers, and ammonium carbonate as a pore former. Powders of different composition showed fairly large and comparable geometric particle sizes (de,50 > 4.4 µm) with effective densities strongly depending on the present matrix former. Powders with lowest density reached an aerosol performance of up to 60%, which is well above most commercial, carrier-based products. It was also demonstrated that the nanomilling step was indispensable to yield such good aerosol performance. Dissolution of aerodynamically classified particle fractions showed a very fast onset and was largely completed within 30 minutes irrespective of the formulation and the impactor stage. Mathematical kinetic modeling was used to deduce the API dissolution rate coefficient from the results obtained using a modified USP 2 apparatus. Dissolution rate was found to be determined by the properties of the API nanoparticles rather than those of the composite particles. The employment of industrially established, solely water-based processes allows introducing the presented approach as a platform technology for the development of well-performing pulmonary formulations.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Wet media milling; dissolution; dry powder inhalation; particle engineering; spray drying

Year:  2019        PMID: 31734282     DOI: 10.1016/j.ejpb.2019.11.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

Review 1.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

2.  The Nanostructure of Polymer-Active Principle Microparticles Produced by Supercritical CO2 Assisted Processing.

Authors:  Ernesto Reverchon; Mariarosa Scognamiglio; Lucia Baldino
Journal:  Nanomaterials (Basel)       Date:  2022-04-19       Impact factor: 5.719

Review 3.  Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections.

Authors:  Xiang Wang; Zuozhou Xie; Jinhong Zhao; Zhenghua Zhu; Chen Yang; Yi Liu
Journal:  Front Cell Infect Microbiol       Date:  2021-12-06       Impact factor: 5.293

4.  Evaluation of the Formulation Parameter-Dependent Redispersibility of API Nanoparticles from Fluid Bed Granules.

Authors:  Martin Wewers; Jan Henrik Finke; Stefan Czyz; Bernard Van Eerdenbrugh; Edgar John; Guido Büch; Michael Juhnke; Heike Bunjes; Arno Kwade
Journal:  Pharmaceutics       Date:  2022-08-13       Impact factor: 6.525

5.  Synthesis, Characterization and In Vitro Evaluation of Chitosan Nanoparticles Physically Admixed with Lactose Microspheres for Pulmonary Delivery of Montelukast.

Authors:  Faqir Ullah; Kifayat Ullah Shah; Shefaat Ullah Shah; Asif Nawaz; Touseef Nawaz; Kamran Ahmad Khan; Raed F Alserihi; Hossam H Tayeb; Shams Tabrez; Mulham Alfatama
Journal:  Polymers (Basel)       Date:  2022-08-29       Impact factor: 4.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.